individual investors
institutions & advisors
My Value Line
Sign In
Subscribe
Value Line
smaller
default
larger
Research Hub
Stocks
Overview
Dow 30 Coverage
Investment Survey
Investment Survey Plus
Small & Midcap Survey
Special Situations
Select
Dividend Select
Value Line 600
Analyzer
Funds
Overview
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options
Overview
Options Survey
Convertibles
Overview
Convertibles Survey
ETF
ETF Professional
Tools
Overview
Screener
Model Portfolio
Portfolio Tracker
Glossary
Markets
Overview
Daily Updates
Economic Calendar
Commentary
Products
Overview
Stocks
Funds
Options
Convertibles
ETFs
Data Licensing
Research Center
Investment Education
Overview
Getting Started
How To Use
Sample Reports
Guides
Articles
FAQs
Glossary
Free Reports
Ranks
Research
My Value Line
Market Review
Symbol Lookup
Products
Research Center
Investment Survey
Investment Survey Plus
Value Line 600
Small & Midcap Survey
Select
Dividend Select
Special Situations
Analyzer
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options Survey
Convertibles Survey
ETF Professional
Free Reports
Need help?
View Our FAQs
Retrieve Password
Contact Us
View Our Guides
Glossary
Quote Lookup
Please enter a ticker symbol below and click Submit.
Symbol:
VL Survey Page
(2013-04-12)
Quotes
News
Option Data
Graphs
Time/Sales
Astrazeneca Plc (AZN)
2013-05-20@13:00:16 ET
Impax Labs launches authorised generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets in US under agreement with AstraZeneca (MTO)
2013-05-20@07:48:41 ET
Global Vaccine Market Forecast to 2017 (MTO)
2013-05-20@07:30:07 ET
Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics (PMZ)
2013-05-17@13:56:29 ET
Volume Spike Detected in Shares of AstraZeneca as They Move Lower on 1.3x Above-Average Volume (AZN) (F82)
2013-05-17@10:39:03 ET
Analyzing the Chemical Industry in the UK 2013 (MTO)
2013-05-16@04:45:00 ET
Cubist, AstraZeneca, Astellas Pharma reportedly bid for Optimer (MTN)
2013-05-15@09:20:16 ET
Potential AstraZeneca (AZN) Trade Targets 5.28% Return (FBM)
2013-05-13@15:00:00 ET
Assessing Your Asthma is Key to Taking Control (PRN)
